A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

F3Z-MC-IOQS -

The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system and to test whether the AID System functions as it was designed to.

Trial Summary

Age Range
18 - 65 years
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
AID System, Insulin Lispro
Could I receive a Placebo?
No
Enrollment Goal
30
Trial Dates
Nov 8, 2017 - Feb 9, 2018
How long will I be in the trial?
Your participation could last about 12 - 18 days and include up to 3 visits to the study center.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.